Cargando…
Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection
Early detection of SARS-CoV-2 infection is critical to reduce asymptomatic and pre-symptomatic transmission, curb the spread of variants by travelers, and maximize treatment efficacy. Low-sensitivity nasal-swab testing (antigen and some nucleic-acid-amplification tests) is commonly used for surveill...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043477/ https://www.ncbi.nlm.nih.gov/pubmed/33851180 http://dx.doi.org/10.1101/2021.04.02.21254771 |
_version_ | 1783678312544993280 |
---|---|
author | Savela, Emily S. Winnett, Alexander Romano, Anna E. Porter, Michael K. Shelby, Natasha Akana, Reid Ji, Jenny Cooper, Matthew M. Schlenker, Noah W. Reyes, Jessica A. Carter, Alyssa M. Barlow, Jacob T. Tognazzini, Colten Feaster, Matthew Goh, Ying-Ying Ismagilov, Rustem F. |
author_facet | Savela, Emily S. Winnett, Alexander Romano, Anna E. Porter, Michael K. Shelby, Natasha Akana, Reid Ji, Jenny Cooper, Matthew M. Schlenker, Noah W. Reyes, Jessica A. Carter, Alyssa M. Barlow, Jacob T. Tognazzini, Colten Feaster, Matthew Goh, Ying-Ying Ismagilov, Rustem F. |
author_sort | Savela, Emily S. |
collection | PubMed |
description | Early detection of SARS-CoV-2 infection is critical to reduce asymptomatic and pre-symptomatic transmission, curb the spread of variants by travelers, and maximize treatment efficacy. Low-sensitivity nasal-swab testing (antigen and some nucleic-acid-amplification tests) is commonly used for surveillance and symptomatic testing, but the ability of low-sensitivity nasal-swab tests to detect the earliest stages of infection has not been established. In this case-ascertained study, initially-SARS-CoV-2-negative household contacts of individuals diagnosed with COVID-19 prospectively self-collected paired anterior-nares nasal-swab and saliva samples twice daily for viral-load quantification by high-sensitivity RT-qPCR and digital-RT-PCR assays. We captured viral-load profiles from the incidence of infection for seven individuals and compared diagnostic sensitivities between respiratory sites. Among unvaccinated persons, high-sensitivity saliva testing detected infection up to 4.5 days before viral loads in nasal swabs reached the limit of detection of low-sensitivity nasal-swab tests. For most participants, nasal swabs reached higher peak viral loads than saliva, but were undetectable or at lower loads during the first few days of infection. High-sensitivity saliva testing was most reliable for earliest detection. Our study illustrates the value of acquiring early (within hours after a negative high-sensitivity test) viral-load profiles to guide the appropriate analytical sensitivity and respiratory site for detecting earliest infections. Such data are challenging to acquire but critical to design optimal testing strategies in the current pandemic and will be required for responding to future viral pandemics. As new variants and viruses emerge, up-to-date data on viral kinetics are necessary to adjust testing strategies for reliable early detection of infections. |
format | Online Article Text |
id | pubmed-8043477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-80434772021-04-14 Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection Savela, Emily S. Winnett, Alexander Romano, Anna E. Porter, Michael K. Shelby, Natasha Akana, Reid Ji, Jenny Cooper, Matthew M. Schlenker, Noah W. Reyes, Jessica A. Carter, Alyssa M. Barlow, Jacob T. Tognazzini, Colten Feaster, Matthew Goh, Ying-Ying Ismagilov, Rustem F. medRxiv Article Early detection of SARS-CoV-2 infection is critical to reduce asymptomatic and pre-symptomatic transmission, curb the spread of variants by travelers, and maximize treatment efficacy. Low-sensitivity nasal-swab testing (antigen and some nucleic-acid-amplification tests) is commonly used for surveillance and symptomatic testing, but the ability of low-sensitivity nasal-swab tests to detect the earliest stages of infection has not been established. In this case-ascertained study, initially-SARS-CoV-2-negative household contacts of individuals diagnosed with COVID-19 prospectively self-collected paired anterior-nares nasal-swab and saliva samples twice daily for viral-load quantification by high-sensitivity RT-qPCR and digital-RT-PCR assays. We captured viral-load profiles from the incidence of infection for seven individuals and compared diagnostic sensitivities between respiratory sites. Among unvaccinated persons, high-sensitivity saliva testing detected infection up to 4.5 days before viral loads in nasal swabs reached the limit of detection of low-sensitivity nasal-swab tests. For most participants, nasal swabs reached higher peak viral loads than saliva, but were undetectable or at lower loads during the first few days of infection. High-sensitivity saliva testing was most reliable for earliest detection. Our study illustrates the value of acquiring early (within hours after a negative high-sensitivity test) viral-load profiles to guide the appropriate analytical sensitivity and respiratory site for detecting earliest infections. Such data are challenging to acquire but critical to design optimal testing strategies in the current pandemic and will be required for responding to future viral pandemics. As new variants and viruses emerge, up-to-date data on viral kinetics are necessary to adjust testing strategies for reliable early detection of infections. Cold Spring Harbor Laboratory 2021-08-26 /pmc/articles/PMC8043477/ /pubmed/33851180 http://dx.doi.org/10.1101/2021.04.02.21254771 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Savela, Emily S. Winnett, Alexander Romano, Anna E. Porter, Michael K. Shelby, Natasha Akana, Reid Ji, Jenny Cooper, Matthew M. Schlenker, Noah W. Reyes, Jessica A. Carter, Alyssa M. Barlow, Jacob T. Tognazzini, Colten Feaster, Matthew Goh, Ying-Ying Ismagilov, Rustem F. Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection |
title | Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection |
title_full | Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection |
title_fullStr | Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection |
title_full_unstemmed | Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection |
title_short | Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection |
title_sort | quantitative sars-cov-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043477/ https://www.ncbi.nlm.nih.gov/pubmed/33851180 http://dx.doi.org/10.1101/2021.04.02.21254771 |
work_keys_str_mv | AT savelaemilys quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT winnettalexander quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT romanoannae quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT portermichaelk quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT shelbynatasha quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT akanareid quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT jijenny quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT coopermatthewm quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT schlenkernoahw quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT reyesjessicaa quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT carteralyssam quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT barlowjacobt quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT tognazzinicolten quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT feastermatthew quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT gohyingying quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection AT ismagilovrustemf quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection |